Toxicological Aspects of Iron Oxide Nanoparticles
- PMID: 35583650
- DOI: 10.1007/978-3-030-88071-2_13
Toxicological Aspects of Iron Oxide Nanoparticles
Abstract
Iron oxide nanoparticles (ION), with unique magnetic properties, have attracted huge scientific attention for a wide variety of uses, mostly in the biomedical field, due to their high biocompatibility, ability to cross biological membranes, appropriate surface architecture and easy conjugation with targeting ligands. Their current applications include diagnostic imaging, cell labelling, site-directed drug delivery and anticancer hyperthermia therapy. The ION surface may be modified by coating with different materials, aiming to stabilize the nanoparticles in different environments, to allow biomolecule binding favouring surface attachments with several molecules, and to prolong the recognition time by the immune system. Although the potential benefits of ION are considerable, and more and more ION are being manufactured to meet the demands of the rapidly proliferating field of nanomedicine, there is an urgent need to define their toxicological profile in order to avoid any potential health risks associated with their exposure and to reach optimal benefits of their use. The purpose of this chapter is to de-scribe the current knowledge on the ION toxicological features, addressing their structure and physicochemical characteristics, main exposure pathways and toxicokinetic aspects, interaction with cells, and their toxic effects, with special attention to those at the cellular and molecular level.
Keywords: Cellular uptake; Cytotoxicity; Genotoxicity; Iron oxide nanoparticles; Physicochemical properties.
© 2022. The Author(s), under exclusive license to Springer Nature Switzerland AG.
Similar articles
-
Recent advances on surface engineering of magnetic iron oxide nanoparticles and their biomedical applications.Nanomedicine (Lond). 2007 Feb;2(1):23-39. doi: 10.2217/17435889.2.1.23. Nanomedicine (Lond). 2007. PMID: 17716188 Review.
-
Magnetic iron oxide nanoparticles for tumor-targeted therapy.Curr Cancer Drug Targets. 2011 Feb;11(2):184-9. doi: 10.2174/156800911794328475. Curr Cancer Drug Targets. 2011. PMID: 21158723 Review.
-
Magnetic iron oxide nanoparticles as drug carriers: preparation, conjugation and delivery.Nanomedicine (Lond). 2018 Apr;13(8):929-952. doi: 10.2217/nnm-2017-0320. Epub 2018 Mar 16. Nanomedicine (Lond). 2018. PMID: 29546817 Review.
-
Chemical synthesis and assembly of uniformly sized iron oxide nanoparticles for medical applications.Acc Chem Res. 2015 May 19;48(5):1276-85. doi: 10.1021/acs.accounts.5b00038. Epub 2015 Apr 29. Acc Chem Res. 2015. PMID: 25922976 Review.
-
Magnetic iron oxide nanoparticles for drug delivery: applications and characteristics.Expert Opin Drug Deliv. 2019 Jan;16(1):69-78. doi: 10.1080/17425247.2019.1554647. Epub 2018 Dec 9. Expert Opin Drug Deliv. 2019. PMID: 30496697 Review.
Cited by
-
Research progress of nanoparticles in diagnosis and treatment of hepatocellular carcinoma.Open Life Sci. 2024 Aug 23;19(1):20220932. doi: 10.1515/biol-2022-0932. eCollection 2024. Open Life Sci. 2024. PMID: 39220591 Free PMC article. Review.
-
Recent Advances in Synergistic Effect of Nanoparticles and Its Biomedical Application.Int J Mol Sci. 2024 Mar 13;25(6):3266. doi: 10.3390/ijms25063266. Int J Mol Sci. 2024. PMID: 38542240 Free PMC article. Review.
-
Magnetic Cell Targeting for Cardiovascular Tissue Engineering.Tissue Eng Part B Rev. 2025 Jun;31(3):234-247. doi: 10.1089/ten.TEB.2024.0103. Epub 2024 Aug 19. Tissue Eng Part B Rev. 2025. PMID: 39078330 Review.
-
Sleep matters: Neurodegeneration spectrum heterogeneity, combustion and friction ultrafine particles, industrial nanoparticle pollution, and sleep disorders-Denial is not an option.Front Neurol. 2023 Feb 27;14:1117695. doi: 10.3389/fneur.2023.1117695. eCollection 2023. Front Neurol. 2023. PMID: 36923490 Free PMC article. Review.
-
Therapeutic and antioxidant potential of bionanofactory Ochrobactrum sp.-mediated magnetite and zerovalent iron nanoparticles against acute experimental toxoplasmosis.PLoS Negl Trop Dis. 2023 Oct 6;17(10):e0011655. doi: 10.1371/journal.pntd.0011655. eCollection 2023 Oct. PLoS Negl Trop Dis. 2023. PMID: 37801440 Free PMC article.
References
-
- Abakumov MA, Semkina AS, Skorikov AS, Vishnevskiy DA, Ivanova AV, Mironova E, Davydova GA, Majouga AG, Chekhonin VP (2018) Toxicity of iron oxide nanoparticles: size and coating effects. J Biochem Mol Toxicol 32:e22225. https://doi.org/10.1002/jbt.22225 - DOI - PubMed
-
- Adeyemi JA, Machado ART, Ogunjimi AT, Alberici LC, Antunes LMG, Barbosa F (2020) Cytotoxicity, mutagenicity, oxidative stress and mitochondrial impairment in human hepatoma (HepG2) cells exposed to copper oxide, copper-iron oxide and carbon nanoparticles. Ecotoxicol Environ Saf 189:109982. https://doi.org/10.1016/j.ecoenv.2019.109982 - DOI - PubMed
-
- Agemy L, Friedmann-Morvinski D, Kotamraju VR, Roth L, Sugahara KN, Girard OM, Mattrey RF, Verma IM, Ruoslahti E (2011) Targeted nanoparticle enhanced proapoptotic peptide as potential therapy for glioblastoma. Proc Natl Acad Sci U S A 108:17450–17455. https://doi.org/10.1073/pnas.1114518108 - DOI - PubMed - PMC
-
- Ahamed M, Alhadlaq HA, Alam J, Majeed Khan MAA, Ali D, Alarafi S (2013) Iron oxide nanoparticle-induced oxidative stress and genotoxicity in human skin epithelial and lung epithelial cell lines. Curr Pharm Des 19:6681–6690. https://doi.org/10.2174/1381612811319370011 - DOI - PubMed
-
- Ahamed M, Akhtar MJ, Khan MAM, Alhadlaq HA, Alshamsan A (2016) Cobalt iron oxide nanoparticles induce cytotoxicity and regulate the apoptotic genes through ROS in human liver cells (HepG2). Colloids Surf B Biointerfaces 148:665–673. https://doi.org/10.1016/j.colsurfb.2016.09.047 - DOI - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources